Clene (CLNN) Restructuring Costs (2024 - 2026)
Clene (CLNN) posted Restructuring Costs of $58000.0 for Q2 2026, up 18.37% on a QoQ basis from $49000.0 in Q4 2025, and down 31.76% year-over-year from $85000.0 in Q2 2025.
Analysis
Clene (CLNN) Restructuring Costs (2024 - 2026) Analysis & Trends
Clene has reported Restructuring Costs for 3 years, with the latest figure at $58000.0 in Q2 2026.
- On a quarterly basis, Restructuring Costs fell 31.76% year-over-year to $58000.0 in Q2 2026; TTM through Jun 2026 was $285000.0, a 57.96% decrease from a year earlier, with the FY2025 full-year figure at $318000.0, down 71.56% from the prior year.
- Restructuring Costs was $58000.0 for Q2 2026 at Clene, up from $49000.0 in the prior quarter.
- The five-year high for Restructuring Costs was $349000.0 in Q2 2024, with the low at $49000.0 in Q4 2025.
- Average Restructuring Costs over 3 years is $166000.0, with a median of $93000.0 recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs plunged 75.64% in 2025, then plunged 31.76% in 2026.
- Over 3 years, Restructuring Costs stood at $174000.0 in 2024, then sank by 71.84% to $49000.0 in 2025, then increased by 18.37% to $58000.0 in 2026.
- The last three Restructuring Costs figures came in at $58000.0 (Q2 2026), $49000.0 (Q4 2025), and $93000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 174,000.00 |
| Sep 30, 2024 | 328,000.00 |
| Jun 30, 2024 | 349,000.00 |
| Mar 31, 2024 | 267,000.00 |